DB18376ExperimentalProtein Based Therapies
TORL-2307 is a humanized immunoglobulin G1 (IgG1) monoclonal antibody (mAb) directed against claudin 18.2 (CLDN18.2) being investigated for the treatment of gastric and pancreatic cancer.
- Code names
- TORL-2307
Which companies are running trials of TORL-2-307, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account